monthsrenalandurologynews.com/hom...
One could read this and construe that that 6 months of ADT would be as good as as 24-36
but of course it does not measure different co-morbidities nor gleason scores and other factors:
The 10-year prostate cancer-specific mortality rates for patients with a PSA nadir of 0.1 ng/mL or higher were 14%, 15%, and 14% for the patients who received RT alone, RT plus short-term ADT, and RT plus long-term ADT, respectively. The rates for patients with a PSA nadir less than 0.1 ng/mL were 8%, 7%, and 7%, respectively.
The 10-year overall survival rates were 58%, 56%, and 50% for patients with a PSA nadir of 0.1 ng/mL or higher, respectively, compared with 52%, 62%, and 63%, respectively, for those with a PSA nadir less than 0.1 ng/mL.